These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 13733279)

  • 1. [Effect of cholinesterase inhibitors on lipolytic activity of the aorta in rats].
    PATELSKI J; SZWEDZIKOWSKI S
    Acta Physiol Pol; 1960; 11():858-9. PubMed ID: 13733279
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of cholinesterase inhibitors on the lipolytic activity of rat aorta.
    SZENDZIKOWSKI S; PATELSKI J; PEARSE AG
    Enzymol Biol Clin (Basel); 1961-1962; 1():125-37. PubMed ID: 13979935
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipolytic and esterolytic activity of aorta after prolonged ACTH treatment in rats.
    PATELSKI J; SZENDZIKOWSKI S
    Bull Soc Amis Sci (Med) (Poznan); 1962; 11():37-47. PubMed ID: 14038217
    [No Abstract]   [Full Text] [Related]  

  • 4. Dietary oleic acid and adipocyte lipolytic activity in culture.
    García-Escobar E; Soriguer F; García-Serrano S; Gómez-Zumaquero JM; Morcillo S; Haro J; Rojo-Martínez G
    J Nutr Biochem; 2008 Nov; 19(11):727-31. PubMed ID: 18328685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dietary conjugated linoleic acid and monounsaturated fatty acid content on pig muscle and adipose tissue lipase and esterase activity.
    Martín D; Ruiz J; Flores M; Toldra F
    J Agric Food Chem; 2006 Nov; 54(24):9241-7. PubMed ID: 17117816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of fatty acid profiles of aorta and internal mammary arteries in patients with coronary artery disease.
    Bahrami G; Ghanbarian E; Masoumi M; Rahimi Z; Rezwan Madani F
    Clin Chim Acta; 2006 Aug; 370(1-2):143-6. PubMed ID: 16563364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of the novel synthetic fatty acid dinitroglycerol esters on aggregation of the human platelets in vitro].
    Vasil'eva TM; Petrukhina GN; Makarov VA; Serkov IV; Gretskaia NM; Bezuglov VV
    Eksp Klin Farmakol; 2003; 66(6):36-41. PubMed ID: 14743709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel inhibitors of fatty acid oxidation as potential metabolic modulators.
    Elzein E; Shenk K; Ibrahim P; Marquart T; Kerwar S; Meyer S; Ahmed H; Zeng D; Chu N; Soohoo D; Wong S; Leung K; Zablocki J
    Bioorg Med Chem Lett; 2004 Feb; 14(4):973-7. PubMed ID: 15013004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of donepezil and lercanidipine on memory impairment induced by intracerebroventricular streptozotocin in rats.
    Sonkusare S; Srinivasan K; Kaul C; Ramarao P
    Life Sci; 2005 May; 77(1):1-14. PubMed ID: 15848214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fatty acids on endothelium-dependent relaxation in the rabbit aorta.
    Edirisinghe I; McCormick Hallam K; Kappagoda CT
    Clin Sci (Lond); 2006 Aug; 111(2):145-51. PubMed ID: 16524362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Finding cholinesterase in endotheliocytes: cholinesterase inhibition by organophosphorus compounds leads to endotheliocyte deformation].
    Prozorovskiĭ VB; Skopichev VG
    Eksp Klin Farmakol; 2005; 68(3):64-7. PubMed ID: 16047685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term fasting and lipolytic activity in rat adipocytes.
    Szkudelski T; Lisiecka M; Nowicka E; Kowalewska A; Nogowski L; Szkudelska K
    Horm Metab Res; 2004 Oct; 36(10):667-73. PubMed ID: 15523590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipolytic activity from Halobacteria: screening and hydrolase production.
    Bhatnagar T; Boutaiba S; Hacene H; Cayol JL; Fardeau ML; Ollivier B; Baratti JC
    FEMS Microbiol Lett; 2005 Jul; 248(2):133-40. PubMed ID: 15979821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of hepatic peroxisomal beta-oxidation of fatty acids by dehydroepiandrosterone (DHEA) in male F-344 rats.
    Khan SA
    Pharmazie; 2008 Dec; 63(12):915-6. PubMed ID: 19177911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiac effects of cholinesterase inhibitors: a reason for restraint?].
    Salarbaks AM; Boomkamp-Snoeren CM; van Puijenbroek E; Jansen PA; van Marum RJ
    Tijdschr Gerontol Geriatr; 2009 Apr; 40(2):79-84. PubMed ID: 19472574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum cholinesterase inhibition by omeprazole and lansoprazole.
    Mequid S; Ramzan I
    Pharmazie; 2004 Sep; 59(9):733. PubMed ID: 15497763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of phospholipids fatty acid composition in reuber H35 hepatoma cells: effect on HMG-CoA reductase activity.
    García-Pelayo MC; García-Peregrín E; Martínez-Cayuela M
    J Cell Biochem; 2003 Oct; 90(3):586-91. PubMed ID: 14523992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered fatty acid metabolism and composition in cultured astrocytes under hyperammonemic conditions.
    Gottschalk S; Zwingmann C
    J Neurochem; 2009 May; 109 Suppl 1():258-64. PubMed ID: 19393036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of studies describing the use of acetyl cholinesterase inhibitors in Parkinson's disease dementia.
    Maidment ID; Fox C; Boustani M
    Acta Psychiatr Scand; 2005 Jun; 111(6):403-9. PubMed ID: 15877706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel carbamate cholinesterase inhibitors that release biologically active amines following enzyme inhibition.
    Verheijen JC; Wiig KA; Du S; Connors SL; Martin AN; Ferreira JP; Slepnev VI; Kochendörfer U
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3243-6. PubMed ID: 19423342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.